Results 151 to 160 of about 39,984 (208)

Rescue of mitochondrial dysfunction through alteration of extracellular matrix composition in barth syndrome cardiac fibroblasts. [PDF]

open access: yesBiomaterials
Piñeiro-Llanes J   +8 more
europepmc   +1 more source

Expanded-access use of elamipretide in a critically ill patient with Barth syndrome. [PDF]

open access: yesGenet Med Open
Goldstein AC   +5 more
europepmc   +1 more source

ECG Findings Are Poor Predictors for Adverse Events and Cardiac Death in Barth Syndrome. [PDF]

open access: yesProg Pediatr Cardiol
Hutchinson A   +3 more
europepmc   +1 more source

Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth syndrome. [PDF]

open access: yesHum Mol Genet
Sniezek Carney O   +8 more
europepmc   +1 more source

Heart injury in Barth syndrome

open access: yesRossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics), 2016
I. V. Leontyeva   +2 more
openaire   +2 more sources

Dietary linoleic acid supplementation fails to rescue established cardiomyopathy in Barth syndrome. [PDF]

open access: yesJ Mol Cell Cardiol Plus
Zhu S   +7 more
europepmc   +1 more source

Temporal Effects of Safflower Oil Diet-Based Linoleic Acid Supplementation on Barth Syndrome Cardiomyopathy. [PDF]

open access: yesCirculation
Zhu S   +10 more
europepmc   +1 more source

Mouse model of Barth syndrome [PDF]

open access: yesScience-Business eXchange, 2010
openaire   +1 more source

A Barth Syndrome Patient-Derived D75H Point Mutation in TAFAZZIN Drives Progressive Cardiomyopathy in Mice. [PDF]

open access: yesInt J Mol Sci
Snider PL   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy